Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02924402
Title Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Xencor, Inc.
Indications

hairy cell leukemia

B-cell adult acute lymphocytic leukemia

chronic lymphocytic leukemia/small lymphocytic lymphoma

B-cell lymphoma

Therapies

XmAb13676

Age Groups: adult | senior
Covered Countries USA | FRA


No variant requirements are available.